Literature DB >> 29981267

Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers.

Wilma Barcellini1, Anna Zaninoni1, Bruno Fattizzo1, Juri Alessandro Giannotta1, Monia Lunghi2, Antonella Ferrari3, Anna Paola Leporace3, Nilla Maschio4, Laura Scaramucci5, Silvia Cantoni6, Federico Chiurazzi7, Dario Consonni8, Giuseppe Rossi9, Paolo De Fabritiis5, Gianluca Gaidano2, Alberto Zanella1, Agostino Cortelezzi1,10.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29981267     DOI： 10.1002/ajh.25212

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  10 in total

1.  Evans syndrome and infections: a dangerous cocktail to manage with caution.

Authors:  Bruno Fattizzo
Journal:  Blood Transfus       Date:  2021-01       Impact factor: 3.443

Review 2.  Development of New Drugs for Autoimmune Hemolytic Anemia.

Authors:  Zhengrui Xiao; Irina Murakhovskaya
Journal:  Pharmaceutics       Date:  2022-05-11       Impact factor: 6.525

3.  Clinical Features and Treatment Outcomes of Warm Autoimmune Hemolytic Anemia: A Retrospective Analysis of 60 Turkish Patients.

Authors:  Fergün Yılmaz; Demet Kiper; Meltem Koç; Tuğçe Karslı; Merve Kılınç; Fusun Gediz; Tayfur Toptaş; Bahriye Payzın
Journal:  Indian J Hematol Blood Transfus       Date:  2019-02-20       Impact factor: 0.900

4.  Disease-modifying treatments for primary autoimmune haemolytic anaemia.

Authors:  Anthony Pak-Yin Liu; Daniel Kl Cheuk
Journal:  Cochrane Database Syst Rev       Date:  2021-03-26

5.  Small Paroxysmal Nocturnal Hemoglobinuria Clones in Autoimmune Hemolytic Anemia: Clinical Implications and Different Cytokine Patterns in Positive and Negative Patients.

Authors:  Bruno Fattizzo; Juri Giannotta; Anna Zaninoni; Austin Kulasekararaj; Lilla Cro; Wilma Barcellini
Journal:  Front Immunol       Date:  2020-06-04       Impact factor: 7.561

6.  Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study.

Authors:  Bruno Fattizzo; Marc Michel; Anna Zaninoni; Juri Giannotta; Stephanie Guillet; Henrik Frederiksen; Josephine M I Vos; Francesca R Mauro; Bernd Jilma; Andrea Patriarca; Francesco Zaja; Anita Hill; Sigbiørn Berentsen; Wilma Barcellini
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

7.  Evans syndrome in adults: an observational multicenter study.

Authors:  Bruno Fattizzo; Marc Michel; Juri Alessandro Giannotta; Dennis Lund Hansen; Maria Arguello; Emanuele Sutto; Nicola Bianchetti; Andrea Patriarca; Silvia Cantoni; María Eva Mingot-Castellano; Vickie McDonald; Marco Capecchi; Anna Zaninoni; Dario Consonni; Josephine Mathilde Vos; Nicola Vianelli; Frederick Chen; Andreas Glenthøj; Henrik Frederiksen; Tomás José González-López; Wilma Barcellini
Journal:  Blood Adv       Date:  2021-12-28

8.  Intravascular hemolysis and multitreatment predict thrombosis in patients with autoimmune hemolytic anemia.

Authors:  Bruno Fattizzo; Marta Bortolotti; Juri Alessandro Giannotta; Anna Zaninoni; Dario Consonni; Wilma Barcellini
Journal:  J Thromb Haemost       Date:  2022-05-30       Impact factor: 16.036

9.  [Ibrutinib treatment for 2 cases of relapsed/refractory autoimmune hemolytic anemia: a pilot study].

Authors:  L W Fang; H Pan; J Shi
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-05-14

10.  Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives.

Authors:  Wilma Barcellini; Bruno Fattizzo; Anna Zaninoni
Journal:  J Blood Med       Date:  2019-08-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.